Abstract
This editorial refers to 'Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal' by U Thadani also published in this issue.
MeSH terms
-
Acetanilides / therapeutic use*
-
Cardiotonic Agents / therapeutic use*
-
Humans
-
Myocardial Ischemia / drug therapy*
-
Piperazines / therapeutic use*
-
Ranolazine
-
Sodium Channel Blockers / therapeutic use*
Substances
-
Acetanilides
-
Cardiotonic Agents
-
Piperazines
-
Sodium Channel Blockers
-
Ranolazine